Literature DB >> 22624675

Genetic polymorphisms of molecules involved in host immune response to dengue virus infection.

Xin Fang1, Zhen Hu, Weilong Shang, Junmin Zhu, Chuanshan Xu, Xiancai Rao.   

Abstract

The dengue virus (DENV) belongs to the flavivirus family. Each of the four distinct serotypes of this virus is capable of causing human disease, especially in tropical and subtropical areas. The majority of people infected with DENV manifest asymptomatic or dengue fever with flu-like self-limited symptoms. However, a small portion of patients emerge with severe manifestations referred to as dengue hemorrhagic fever, which has a high mortality rate if not treated promptly. The host immune system, which plays important roles throughout the whole process of DENV infection, has been confirmed to have double-edged effects on DENV infection. Recently, much attention has been paid to the genetic heterogeneity of molecules involved in the host immune response to DENV infection. This heterogeneity has been proved to be the determining factor for DENV disease orientation. The present review discusses the primary functions and single nucleotide polymorphisms of some critical molecules in the human DENV immunological defense, especially the polymorphism locus associated with the DENV pathogenesis and disease susceptibility.
© 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22624675     DOI: 10.1111/j.1574-695X.2012.00995.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  7 in total

1.  Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression.

Authors:  André F Pastor; Laís Rodrigues Moura; José W D Neto; Eduardo J M Nascimento; Carlos E Calzavara-Silva; Ana Lisa V Gomes; Ana Maria da Silva; Marli T Cordeiro; Ulisses Braga-Neto; Sergio Crovella; Laura H V G Gil; Ernesto T A Marques; Bartolomeu Acioli-Santos
Journal:  Hum Immunol       Date:  2013-06-06       Impact factor: 2.850

2.  Polymorphisms of Transporter Associated with Antigen Presentation, Tumor Necrosis Factor-α and Interleukin-10 and their Implications for Protection and Susceptibility to Severe Forms of Dengue Fever in Patients in Sri Lanka.

Authors:  Anira N Fernando; Gathsaurie Neelika Malavige; Kuda Liyanage Nandika Perera; Sunil Premawansa; Graham S Ogg; Aruna Dharshan De Silva
Journal:  J Glob Infect Dis       Date:  2015 Oct-Dec

3.  Role of Interleukin-10 and Abdominopelvic Ultrasound as a Potential Predictor of Disease Severity in Dengue Hemorrhagic Fever.

Authors:  Ambreen Tauseef; Farhat Ijaz; Farid Ahmad Chaudhary; Zaima Ali; Tanzeela Akram; Rana Khurram Aftab; Gulfam Ahmad
Journal:  Cureus       Date:  2019-07-27

4.  Small G Rac1 is involved in replication cycle of dengue serotype 2 virus in EAhy926 cells via the regulation of actin cytoskeleton.

Authors:  Jing Zhang; Na Wu; Na Gao; Wenli Yan; Ziyang Sheng; Dongying Fan; Jing An
Journal:  Sci China Life Sci       Date:  2016-04-07       Impact factor: 6.038

Review 5.  Is there a risk of yellow fever virus transmission in South Asian countries with hyperendemic dengue?

Authors:  Suneth B Agampodi; Kolitha Wickramage
Journal:  Biomed Res Int       Date:  2013-12-03       Impact factor: 3.411

6.  A replication study confirms the association of GWAS-identified SNPs at MICB and PLCE1 in Thai patients with dengue shock syndrome.

Authors:  Tran Ngoc Dang; Izumi Naka; Areerat Sa-Ngasang; Surapee Anantapreecha; Sumalee Chanama; Nuanjun Wichukchinda; Pathom Sawanpanyalert; Jintana Patarapotikul; Naoyuki Tsuchiya; Jun Ohashi
Journal:  BMC Med Genet       Date:  2014-05-17       Impact factor: 2.103

7.  Increased TNF-α Initiates Cytoplasmic Vacuolization in Whole Blood Coculture with Dengue Virus.

Authors:  Rahmat Dani Satria; Tzu-Wen Huang; Ming-Kai Jhan; Ting-Jing Shen; Po-Chun Tseng; Yun-Ting Wang; Zhen-Yu Yang; Chung-Hsi Hsing; Chiou-Feng Lin
Journal:  J Immunol Res       Date:  2021-05-06       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.